Skip to main content
search

Sessions:

Wednesday, 29 April 2026 | 10:00-10:45 am ET
Friday, 1 May 2026 | 10:00-10:45 am CET
Friday, 1 May 2026 | 10:00-10:45 am IST

Products: Pinnacle 21®

Pinnacle 21 Community plays an important role in the clinical data ecosystem. It is a valuable, open-source desktop tool for core SDTM, SEND, ADaM, and Define.xml validation, supported by an active user forum that helps teams troubleshoot and share practical experience. For many users, it remains an effective starting point for validation report generation.

But is Community always the best resource for a study? Pinnacle 21 Enterprise extends the value of validation by adding centralized issue management, validation history, change tracking, configurable standards, data fitness scoring, and automation for Define.xml and Study Data Reviewer’s Guides. Depending on the study, these capabilities can deliver essential time savings, validation assurance, and submission-readiness insights.

This webinar will examine the practical decision points: study complexity, number of stakeholders, need for audit trail and issue ownership, expectations for Define.xml and Reviewer’s Guide creation, and the level of submission-readiness visibility a team needs before filing. We will explore how these capabilities:

  • improve data quality assurance and workflow efficiency across the study lifecycle
  • reduce manual rework and spreadsheet-based coordination
  • help teams move toward more consistent, submission-ready SDTM and ADaM packages

Register now


For many studies, Pinnacle 21 Enterprise means lower remediation costs, fewer avoidable delays, and a higher probability that datasets are accepted for regulatory review without unnecessary risk.

Join us to examine the key differences between Community and Enterprise, to help determine which is right for your study.

What you will learn

  • Where Pinnacle 21 Community delivers strong value today
  • What functional differences matter most when evaluating Enterprise for a study
  • How issue management, validation history, and change tracking impact quality and efficiency
  • How Define.xml and Reviewer’s Guide automation may reduce end-stage submission burden
  • What to consider when balancing cost, complexity, compliance expectations, and submission readiness for SDTM and ADaM datasets

Who should attend

  • Clinical programmers
  • Statistical programmers
  • Biostatisticians
  • Data Standards Managers
  • Clinical Data Managers

Speaker:

Jen Manzi

Jen Manzi

Subject Matter Expert and User Advocate, Pinnacle 21 by Certara

Jen Manzi is a Subject Matter Expert and User Advocate at Pinnacle 21. She has over 20 years of Pharma/Life Sciences industry experience in Clinical Trials and Safety Data Management. Jen has held various roles within these areas, including eCRF Programmer, SDTM Delivery Lead, Product Owner and Programmer of Batch Processes, Vendor Relationship Manager, Program and Process Improvement Manager, and Validation Lead.

Register now